Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacogenomics of Stimulant Treatment Response in Children and Adolescents With Attention-Deficit/ Hyperactivity Disorder

NCT06221358 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.

NCT NCT06221358
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06221358 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacogenomics of Stimulant Treatment Response in Children and Adolescents With Attention-Deficit/ Hyperactivity Disorder
Lead sponsor
University of Calgary
Phase
Observational
Overall status
Recruiting
Start date
April 1, 2024
Completion date
December 31, 2028
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

attention-deficit/ hyperactivity disorder (adhd)